Blood cyclosporin concentrations and renal allograft dysfunction

Area of Science:

• Nephrology
• Immunology
• Pharmacology

Background:

• Renal allograft recipients often experience renal dysfunction post-transplantation.
• Cyclosporin is a common immunosuppressant, but its therapeutic window is narrow, posing risks of toxicity and rejection.

Purpose of the Study:

• To investigate the relationship between predose blood cyclosporin concentrations and the causes of renal dysfunction in renal allograft recipients.
• To determine the clinical utility of cyclosporin monitoring in differentiating between graft rejection and cyclosporin-induced nephrotoxicity.

Main Methods:

• Prospective study of 49 renal allograft recipients over six months.
• Diagnosis of graft rejection or nephrotoxicity based on allograft biopsy histology and treatment response.
• Radioimmunoassay measurement of predose blood cyclosporin concentrations.

Main Results:

• Mean predose blood cyclosporin concentrations were significantly higher during episodes of toxicity (741 nmol/l) compared to rejection (392 nmol/l).
• Higher frequency of cyclosporin levels >666 nmol/l associated with toxicity; lower frequency <333 nmol/l associated with rejection.
• Cyclosporin levels at the time of biopsy were less effective in distinguishing between toxicity and rejection.

Conclusions:

• Blood cyclosporin monitoring, particularly predose levels over the preceding week, is clinically valuable for distinguishing between cyclosporin toxicity and graft rejection.
• Radioimmunoassay, despite lacking specificity for the parent compound, aids in optimizing cyclosporin treatment in renal transplant patients.